Developer docs
API playgroundTry for free, no card

Search company profiles

Will - Pharma

Full company profile

uuid02f8bbs

Namestring
Will - Pharma
Legal namestring
Will-Pharma SA
Websiteurl
willpharma.com
Company typeenum
Private
Founded yearint
1924
Descriptiontext

Will Pharma is a family-owned, independent mid-sized pharmaceutical company headquartered in Wavre, Belgium, founded in 1924 by Ludwig Frederich Will in Amsterdam. The company develops and manufactures healthcare products for the Benelux market across four categories: prescription medicines (rheumatology, gastroenterology, proctology, dermatology, gynecology), food supplements (D-Vital calcium/vitamin D line, Vitamin D Will, Vitamin C Will Boost, Cogniton cognitive line), cosmetics (Cose-Protect line), and medical devices (Willocare: Willocell, Willomesh, Willospon). Therapeutic franchises include Tempocol peppermint oil for IBS (with peer-reviewed PERSUADE study support published in Gastroenterology), the D-Vital/Vitamin D range, MYK antifungal sulconazole products, TOLPERMYO muscle relaxant, CINACALCET, and TRIANAL proctology products.

The company operates a centralized 2,500 m² Benelux distribution warehouse in Wavre, with regional offices in Schiphol-Rijk (Netherlands) and Hobscheid (Luxembourg). Its business model centers on regulated pharmaceutical product sales through wholesale distributors (Mosadex, Pluripharm, Alliance Healthcare, Brocacef, GLN, Proktovar), direct pharmacy supply, and targeted hospital supply, complemented by a business development programme for in-licensing and out-licensing partnerships. Go-to-market is sales-led via field representatives targeting pharmacists and physicians.

Revenue mechanics are based on one-time product sales of prescription medications, OTC products, food supplements, medical devices, and cosmetics, with a minimum delivery fee of EUR 12.40 per order under EUR 500. The company emphasizes full regulatory compliance with FAGG (Belgium), CBG (Netherlands), and Luxembourg authorities, sustained by an outsourced pharmacovigilance system through partner Qplus Consult.

Short descriptiontext

Will Pharma is a family-owned, independent Benelux pharmaceutical company (founded 1924) that develops, manufactures, and distributes prescription medicines, food supplements, cosmetics, and medical devices through wholesalers, pharmacies, and hospitals in Belgium, the Netherlands, and Luxembourg.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBierges, Belgium
HQ citystring
Bierges
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, prescription medications, food supplements, medical devices, consumer healthcare
Industry4 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Will Pharma develops and manufactures healthcare products and sells them through wholesale distributors, pharmacies, and hospitals in the Benelux market. Products include prescription medicines, OTC products, food supplements, medical devices, and cosmetics.

willpharma.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Willocare
Description

Medical products sub-brand for capillary, venous, and minor arterial bleeding products including Willocell, Willomesh, and Willospon.

willpharma.com
Core offering1 text field

Will Pharma develops, manufactures and distributes a portfolio of prescription medicines, OTC products, food supplements, medical devices and cosmetics in the Benelux market. Therapeutic focus areas include rheumatology, gastroenterology, proctology, dermatology, gynecology and cardiovascular health. Products are sold through wholesale distributors, pharmacies and hospitals, with the company also pursuing in-licensing and out-licensing partnerships to expand its portfolio.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Centralizing logistics saves 12,000 transport kilometers per year
+1 more record
Product overview1 text field

Will Pharma is a family-owned independent mid-sized pharmaceutical company with a strong market position in the Benelux (Belgium, Netherlands, Luxembourg), with 100 years of experience since founding in 1924. The company develops and manufactures healthcare products in collaboration with carefully selected partners and manages all required quality and regulatory compliance for successful market launch. Will Pharma's portfolio is organized across four main product categories: (1) prescription medicines (medical products) covering therapeutic areas including rheumatology, gastroenterology, proctology, dermatology, and gynecology; (2) food supplements including the D-VITAL calcium/vitamin D line, Vitamin D Will, Vitamin C Will Boost, and the Cogniton cognitive support line; (3) cosmetics including Cose-Protect and Cose-Protect Duo for perianal skin care; and (4) medical devices including the Willocare line (Willocell, Willomesh, Willospon) for stopping capillary, venous, and minor arterial bleeding. The company's main therapeutic focus areas are rheumatology, gastroenterology, proctology, and dermatology. Will Pharma also operates a business development programme involving in-licensing (acquiring products to commercialize in the Benelux) and out-licensing (granting licenses for its products in international markets).

Product and service14 records
1D-Vital Calcium K
CategoryMedical devices (rheumatology / bone health)
Description

Medical device calcium supplement providing calcium carbonate with vitamin K2 and vitamin D3, indicated for bone health support across life stages including growth, pregnancy, menopause and elderly populations.

2Cose-Protect Duo
CategoryCosmetics (proctology)
Description

Cosmetic intimate care cream containing polidocanol, sodium oleate, hesperidin and diosmin, formulated to soothe the perianal area and support skin regeneration.

3Vitamin D Will
CategoryMedical products (prescription)
Description

Registered medicine in the Vitamin D Will line offering 25,000 IU cholecalciferol per soft capsule for prevention and treatment of vitamin D deficiency, including loading-dose and osteoporosis maintenance regimens.

4Vitamin C Will Boost
CategoryFood supplements
Description

Food supplement releasing 1,000 mg of vitamin C using immediate and extended-release technology for immune support, antioxidant activity, wound healing and energy metabolism.

5Combizym Forte
CategoryFood supplements (gastroenterology)
Description

Food supplement combining protease, lipase, amylase, plant enzymes from Aspergillus oryzae, calcium and lactase for enhanced digestive enzyme support and lactose digestion.

6Tempocol
CategoryMedical products (gastroenterology)
Description

Gastroenterology prescription product containing peppermint oil capsules with gastro-resistant coating for the treatment of Irritable Bowel Syndrome (IBS). Clinically proven in the PERSUADE study published in Gastroenterology to reduce abdominal pain and IBS symptoms.

7MYK-1 Crème
CategoryMedical products (dermatology)
Description

Prescription antifungal cream containing sulconazole nitrate for the treatment of skin fungal infections.

8Willocare (Willocell, Willomesh, Willospon)
CategoryMedical devices (Willocare line)
Description

Medical device hemostatic product line (sub-brand Willocare) including Willocell, Willomesh and Willospon designed to stop capillary, venous and minor arterial bleeding.

9Tolpermyo
CategoryMedical products (prescription)
Description

Prescription muscle relaxant medicine for the treatment of spasticity, available in 50 mg and 150 mg dosages.

10Cinacalcet
CategoryMedical products (prescription)
Description

Prescription medicine for internal medicine applications, available in 30 mg, 60 mg and 90 mg dosages.

11TriAnal
CategoryMedical products (proctology)
Description

Proctology prescription product for anal/rectal support, available in standard form and as TriAnal Zetpil suppository.

12Mediaven Forte
CategoryMedical products (cardiovascular)
Description

Prescription cardiovascular product in the heart and vascular diseases category, available as 30 mg dosage.

13Donnafyta Meno
CategoryMedical products (gynecology)
Description

Gynecology product designed for menopausal support.

14Cogniton Line
CategoryFood supplements (cognitive support)
Description

Food supplement line for cognitive support including Cogniton Focus, Cogniton Focus LA, Cogniton Huperzia, and Cogniton Plus Energy LA variants.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
1Meodyne
Strategic tierNot SpecifiedTypeStrategic or Co-development Partner
Description

Healthcare partner mentioned on Will Pharma's partner page, collaborating on patient care solutions.

willpharma.com
Strategic tierNot SpecifiedTypeStrategic or Co-development Partner
Description

Patient association partnership for Irritable Bowel Syndrome, collaborating on research for Tempocol effectiveness.

3Mosadex
Strategic tierNot SpecifiedTypeChannel Partner/ Reseller/ Distributor
Description

Dutch pharmaceutical wholesale partner for distribution of Will Pharma products.

willpharma.com
4Proktovar
Strategic tierNot SpecifiedTypeChannel Partner/ Reseller/ Distributor
Description

Healthcare distribution partner for Will Pharma products.

willpharma.com
Strategic tierNot SpecifiedTypeChannel Partner/ Reseller/ Distributor
Description

Dutch pharmacy purchasing organization and wholesale partner.

Strategic tierNot SpecifiedTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical wholesale and distribution partner.

Strategic tierNot SpecifiedTypeChannel Partner/ Reseller/ Distributor
Description

Dutch pharmaceutical wholesale and distribution partner.

Strategic tierNot SpecifiedTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical wholesale partner.

9Qplus Consult
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Pharmacovigilance partner handling adverse event reporting on behalf of Will Pharma, as required by regulatory obligations.

willpharma.com
Strategic tierNot SpecifiedTypeStrategic or Co-development Partner
Description

Research funding partner for PERSUADE study on Tempocol peppermint oil effectiveness, funded by ZonMW GGG programme.

Strategic tierNot SpecifiedTypeStrategic or Co-development Partner
Description

Academic medical center conducting PERSUADE research study on Tempocol effectiveness for IBS symptoms.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

European-focused generic and specialty pharma with strong Benelux pharmacy distribution; competes across OTC, generics, and specialty categories relevant to Will Pharma's portfolio.

TypeBroad incumbent
Description

European specialty pharma with focus areas (gastroenterology, endocrinology) that overlap with Will Pharma's Tempocol and DonnaFyta Meno franchises.

TypeBroad incumbent
Description

Major OTC and consumer healthcare player with deep European pharmacy presence; overlaps with Will Pharma's supplement and OTC positioning.

TypeDirect peer
Description

Benelux-based specialty pharma and OTC player with comparable therapeutic categories (dermatology, gastro, women's health) and pharmacy-channel distribution model.

5Sandoz
TypeBroad incumbent
Description

Global generic and specialty pharma leader; competes directly with Will Pharma's generic SKUs (Cinacalcet, Tolpermyo) and exerts pricing pressure across European tender markets.

TypeDirect peer
Description

Dutch mid-sized specialty pharma company focused on Benelux markets with a similar in-licensing model, niche specialty product portfolio, and field sales targeting physicians and pharmacies.

TypeBroad incumbent
Description

World's largest generic manufacturer with significant Benelux operations; direct overlap on generic prescription portfolio and benchmark for tender pricing pressure.

TypeDirect peer
Description

Italian specialty pharma with established Benelux commercial footprint, competing in similar therapeutic niches including gastroenterology and women's health with branded prescription products.

9Qplus Consult
TypeOthers
Description

Benelux pharmacovigilance and regulatory consulting partner; classified as ecosystem/adjacent enabler rather than competitor, providing Will Pharma's PV infrastructure.

TypeDirect peer
Description

European specialty pharma with strong Benelux presence and a comparable mix of branded Rx, OTC, and consumer healthcare products distributed through pharmacies.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Will - Pharma

Pharmaceutical Manufacturingwillpharma.com

Will Pharma is a family-owned, independent Benelux pharmaceutical company (founded 1924) that develops, manufactures, and distributes prescription medicines, food supplements, cosmetics, and medical devices through wholesalers, pharmacies, and hospitals in Belgium, the Netherlands, and Luxembourg.

What Will - Pharma does

Will Pharma is a family-owned, independent mid-sized pharmaceutical company headquartered in Wavre, Belgium, founded in 1924 by Ludwig Frederich Will in Amsterdam. The company develops and manufactures healthcare products for the Benelux market across four categories: prescription medicines (rheumatology, gastroenterology, proctology, dermatology, gynecology), food supplements (D-Vital calcium/vitamin D line, Vitamin D Will, Vitamin C Will Boost, Cogniton cognitive line), cosmetics (Cose-Protect line), and medical devices (Willocare: Willocell, Willomesh, Willospon). Therapeutic franchises include Tempocol peppermint oil for IBS (with peer-reviewed PERSUADE study support published in Gastroenterology), the D-Vital/Vitamin D range, MYK antifungal sulconazole products, TOLPERMYO muscle relaxant, CINACALCET, and TRIANAL proctology products.

The company operates a centralized 2,500 m² Benelux distribution warehouse in Wavre, with regional offices in Schiphol-Rijk (Netherlands) and Hobscheid (Luxembourg). Its business model centers on regulated pharmaceutical product sales through wholesale distributors (Mosadex, Pluripharm, Alliance Healthcare, Brocacef, GLN, Proktovar), direct pharmacy supply, and targeted hospital supply, complemented by a business development programme for in-licensing and out-licensing partnerships. Go-to-market is sales-led via field representatives targeting pharmacists and physicians.

Revenue mechanics are based on one-time product sales of prescription medications, OTC products, food supplements, medical devices, and cosmetics, with a minimum delivery fee of EUR 12.40 per order under EUR 500. The company emphasizes full regulatory compliance with FAGG (Belgium), CBG (Netherlands), and Luxembourg authorities, sustained by an outsourced pharmacovigilance system through partner Qplus Consult.

Will - Pharma firmographics

Firmographics
Name
Will - Pharma
Legal name
Will-Pharma SA
Website
https://willpharma.com
Company type
Private
Founded year
1924
Operating status
Operating
Headcount range
51–100 employees
Short description
Will Pharma is a family-owned, independent Benelux pharmaceutical company (founded 1924) that develops, manufactures, and distributes prescription medicines, food supplements, cosmetics, and medical devices through wholesalers, pharmacies, and hospitals in Belgium, the Netherlands, and Luxembourg.
Ownership category
akta.pro rank

Will - Pharma industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products

Keywords

  • Pharmaceutical manufacturing
  • Prescription medications
  • Food supplements
  • Medical devices
  • Consumer healthcare

Where Will - Pharma is headquartered

Location

Headquarters

HQ city
Bierges
HQ country
Belgium
HQ region
Europe

Offices3 records

Markets served

Will - Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Will Pharma develops and manufactures healthcare products and sells them through wholesale distributors, pharmacies, and hospitals in the Benelux market. Products include prescription medicines, OTC products, food supplements, medical devices, and cosmetics.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Will - Pharma product offering

Product offering

Core offering

Will Pharma develops, manufactures and distributes a portfolio of prescription medicines, OTC products, food supplements, medical devices and cosmetics in the Benelux market. Therapeutic focus areas include rheumatology, gastroenterology, proctology, dermatology, gynecology and cardiovascular health. Products are sold through wholesale distributors, pharmacies and hospitals, with the company also pursuing in-licensing and out-licensing partnerships to expand its portfolio.

Product overview

Will Pharma is a family-owned independent mid-sized pharmaceutical company with a strong market position in the Benelux (Belgium, Netherlands, Luxembourg), with 100 years of experience since founding in 1924. The company develops and manufactures healthcare products in collaboration with carefully selected partners and manages all required quality and regulatory compliance for successful market launch. Will Pharma's portfolio is organized across four main product categories: (1) prescription medicines (medical products) covering therapeutic areas including rheumatology, gastroenterology, proctology, dermatology, and gynecology; (2) food supplements including the D-VITAL calcium/vitamin D line, Vitamin D Will, Vitamin C Will Boost, and the Cogniton cognitive support line; (3) cosmetics including Cose-Protect and Cose-Protect Duo for perianal skin care; and (4) medical devices including the Willocare line (Willocell, Willomesh, Willospon) for stopping capillary, venous, and minor arterial bleeding. The company's main therapeutic focus areas are rheumatology, gastroenterology, proctology, and dermatology. Will Pharma also operates a business development programme involving in-licensing (acquiring products to commercialize in the Benelux) and out-licensing (granting licenses for its products in international markets).

Differentiator

Problem solved

Functional benefit

Brands

  • Willocare: Medical products sub-brand for capillary, venous, and minor arterial bleeding products including Willocell, Willomesh, and Willospon.

Products and services

  • D-Vital Calcium K Medical device calcium supplement providing calcium carbonate with vitamin K2 and vitamin D3, indicated for bone health support across life stages including growth, pregnancy, menopause and elderly populations.
  • Cose-Protect Duo Cosmetic intimate care cream containing polidocanol, sodium oleate, hesperidin and diosmin, formulated to soothe the perianal area and support skin regeneration.
  • Vitamin D Will Registered medicine in the Vitamin D Will line offering 25,000 IU cholecalciferol per soft capsule for prevention and treatment of vitamin D deficiency, including loading-dose and osteoporosis maintenance regimens.
  • Vitamin C Will Boost Food supplement releasing 1,000 mg of vitamin C using immediate and extended-release technology for immune support, antioxidant activity, wound healing and energy metabolism.
  • Combizym Forte Food supplement combining protease, lipase, amylase, plant enzymes from Aspergillus oryzae, calcium and lactase for enhanced digestive enzyme support and lactose digestion.
  • Tempocol Gastroenterology prescription product containing peppermint oil capsules with gastro-resistant coating for the treatment of Irritable Bowel Syndrome (IBS). Clinically proven in the PERSUADE study published in Gastroenterology to reduce abdominal pain and IBS symptoms.
  • MYK-1 Crème Prescription antifungal cream containing sulconazole nitrate for the treatment of skin fungal infections.
  • Willocare (Willocell, Willomesh, Willospon) Medical device hemostatic product line (sub-brand Willocare) including Willocell, Willomesh and Willospon designed to stop capillary, venous and minor arterial bleeding.
  • Tolpermyo Prescription muscle relaxant medicine for the treatment of spasticity, available in 50 mg and 150 mg dosages.
  • Cinacalcet Prescription medicine for internal medicine applications, available in 30 mg, 60 mg and 90 mg dosages.
  • TriAnal Proctology prescription product for anal/rectal support, available in standard form and as TriAnal Zetpil suppository.
  • Mediaven Forte Prescription cardiovascular product in the heart and vascular diseases category, available as 30 mg dosage.
  • Donnafyta Meno Gynecology product designed for menopausal support.
  • Cogniton Line Food supplement line for cognitive support including Cogniton Focus, Cogniton Focus LA, Cogniton Huperzia, and Cogniton Plus Energy LA variants.

Quantifiable outcome

  • Centralizing logistics saves 12,000 transport kilometers per year
  • +1 more outcomes

Companies that use Will - Pharma

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Will - Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature2 records

Will - Pharma partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered not specified and core.

  • Meodynenot specifiedStrategic or Co-development PartnerHealthcare partner mentioned on Will Pharma's partner page, collaborating on patient care solutions.
  • PDSB (Prikkelbare Darm Syndroom Belangenvereniging)not specifiedStrategic or Co-development PartnerPatient association partnership for Irritable Bowel Syndrome, collaborating on research for Tempocol effectiveness.
  • Mosadexnot specifiedChannel Partner/ Reseller/ DistributorDutch pharmaceutical wholesale partner for distribution of Will Pharma products.
  • Proktovarnot specifiedChannel Partner/ Reseller/ DistributorHealthcare distribution partner for Will Pharma products.
  • Pluripharmnot specifiedChannel Partner/ Reseller/ DistributorDutch pharmacy purchasing organization and wholesale partner.
  • Alliance Healthcarenot specifiedChannel Partner/ Reseller/ DistributorInternational pharmaceutical wholesale and distribution partner.
  • Brocacefnot specifiedChannel Partner/ Reseller/ DistributorDutch pharmaceutical wholesale and distribution partner.
  • GLN (Groothandel)not specifiedChannel Partner/ Reseller/ DistributorPharmaceutical wholesale partner.
  • Qplus ConsultcoreImplementation/ SI/ Consulting PartnerPharmacovigilance partner handling adverse event reporting on behalf of Will Pharma, as required by regulatory obligations.
  • ZonMW (Good Use of Medicines Programme)not specifiedStrategic or Co-development PartnerResearch funding partner for PERSUADE study on Tempocol peppermint oil effectiveness, funded by ZonMW GGG programme.
  • MUMC+ (Maastricht UMC+)not specifiedStrategic or Co-development PartnerAcademic medical center conducting PERSUADE research study on Tempocol effectiveness for IBS symptoms.

Scale indicators5 records

Recent moves10 records

Expansion highlights6 records

Will - Pharma competitors and assessment

Company assessment

Broad incumbents

  • STADA Arzneimittel: European-focused generic and specialty pharma with strong Benelux pharmacy distribution; competes across OTC, generics, and specialty categories relevant to Will Pharma's portfolio.
  • Ipsen: European specialty pharma with focus areas (gastroenterology, endocrinology) that overlap with Will Pharma's Tempocol and DonnaFyta Meno franchises.
  • Perrigo Company: Major OTC and consumer healthcare player with deep European pharmacy presence; overlaps with Will Pharma's supplement and OTC positioning.
  • Sandoz: Global generic and specialty pharma leader; competes directly with Will Pharma's generic SKUs (Cinacalcet, Tolpermyo) and exerts pricing pressure across European tender markets.
  • Teva Pharmaceutical Industries: World's largest generic manufacturer with significant Benelux operations; direct overlap on generic prescription portfolio and benchmark for tender pricing pressure.

Direct peers

  • Vemedia: Benelux-based specialty pharma and OTC player with comparable therapeutic categories (dermatology, gastro, women's health) and pharmacy-channel distribution model.
  • Eurocept Pharmaceuticals: Dutch mid-sized specialty pharma company focused on Benelux markets with a similar in-licensing model, niche specialty product portfolio, and field sales targeting physicians and pharmacies.
  • Zambon: Italian specialty pharma with established Benelux commercial footprint, competing in similar therapeutic niches including gastroenterology and women's health with branded prescription products.
  • Therabel Pharmaceuticals: European specialty pharma with strong Benelux presence and a comparable mix of branded Rx, OTC, and consumer healthcare products distributed through pharmacies.

Others

  • Qplus Consult: Benelux pharmacovigilance and regulatory consulting partner; classified as ecosystem/adjacent enabler rather than competitor, providing Will Pharma's PV infrastructure.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Will - Pharma social profiles

Digital presence

Will - Pharma compliance and trust

Trust signal

Compliance1 record

Will - Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Will - Pharma leadership team

Management profile

Number of profiles

Profiles6 records

Will - Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Will - Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Will - Pharma

What does Will - Pharma do?

Will Pharma develops, manufactures and distributes a portfolio of prescription medicines, OTC products, food supplements, medical devices and cosmetics in the Benelux market. Therapeutic focus areas include rheumatology, gastroenterology, proctology, dermatology, gynecology and cardiovascular health. Products are sold through wholesale distributors, pharmacies and hospitals, with the company also pursuing in-licensing and out-licensing partnerships to expand its portfolio.

Is Will - Pharma a public or private company?

Will - Pharma is a private company. It is classified as family owned and is currently operating.

When was Will - Pharma founded?

Will - Pharma was founded in 1924. It employs 51 to 100 people.

Where is Will - Pharma based?

Will - Pharma is headquartered in Bierges, Belgium, in the Europe region.

How does Will - Pharma make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Will - Pharma's main competitors?

Broad incumbents on record are STADA Arzneimittel, Ipsen, Perrigo Company, Sandoz and Teva Pharmaceutical Industries. Direct peers are Vemedia, Eurocept Pharmaceuticals, Zambon and Therabel Pharmaceuticals. Qplus Consult is listed as an others.

Does Will - Pharma have an API?

No public API is recorded for Will - Pharma.

What industry is Will - Pharma in?

Will - Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales